Market Research Report
Global Enteral Feeding Formulas Market Size study, by Product, by Flow Type, by Stage, Indication, End-user and Regional Forecasts 2021-2027
|Published by||Bizwit Research & Consulting LLP||Product code||1019280|
Delivery time: 2-3 business days
|Global Enteral Feeding Formulas Market Size study, by Product, by Flow Type, by Stage, Indication, End-user and Regional Forecasts 2021-2027|
|Published: July 17, 2021||Content info:||
Global Enteral Feeding Formulas Market is valued approximately at USD 5.95 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2021-2027. Enteral feeding formulas are for the people who are not able to eat or digest normally due to a condition or injury that prevents eating a regular diet by mouth. Rising trend of preterm births is growing the demand in the market. Growing prevalence of chronic diseases such as cancer and diabetes, new product launches by private players and rising geriatric population around the world is growing the demand for eternal feeding formulas in the market. For instance, according to American Cancer Society, the number of new cancer cases in United States was 1,762,450 which was expected to reach 1.8 million in 2020. Also, in 2020, Victus, Inc. launched Abintra Care, a specialized nutrition that can support the immune system. Furthermore, technological advancements in products and growing preference for consumption of disease specific formulas are expected to fuel the growth in near future. However, lack of awareness for clinical nutrition in medical and healthcare community and complications associated with enteral feeding may hamper the growth during forecast period.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis. North America is dominating across the world in terms of revenue due to growing burden of chronic diseases such as cancer, diabetes and other neurological conditions. Whereas Asia Pacific is anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing number of preterm birth and improvement in healthcare infrastructure.
Major market player included in this report are:
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co., Ltd.
Reckitt Benckiser Group Plc.
Mead Johnson Nutrition Company
B. Braun Melsungen AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Flow Type:
Intermittent feeding flow
Continuous feeding flow
Chronic Kidney Diseases
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Enteral Feeding Formulas Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers
a. Market Snapshot
b. Market Snapshot
c. Market Snapshot
d. Market Snapshot
List of figures